News - BioPharm International

ADVERTISEMENT

News

AstraZeneca to Invest in New Manufacturing Facility for Injectable Drug

November 11, 2013

AstraZeneca will build a new facility in the United Kingdom to produce Zoladex, an injectable prostrate cancer treatment.

Grifols Purchases Novartis Transfusion Diagnostics Unit

November 11, 2013

Grifols expands and diversifies portfolio with acquisition of diagnostic business.

BIO Throws its Support for Start-up Jobs and Innovation Act

November 7, 2013

Biotechnology Industry Organization President James Greenwood writes senators in support of Start-up Jobs and Innovation Act.

Novartis Announced as Facility of the Year Awards Overall Winner

November 6, 2013

ISPE names Novartis' US Flu Cell Culture facility as award winner.

ISPE Releases Report on Survey of Patient Experiences with Clinical Trial Materials

November 6, 2013

ISPE’s survey is industry’s first large-scale effort to collect data on patient experiences with clinical trial materials.

FDA Releases Pulmonary Tuberculosis Guidance

November 5, 2013

FDA releases guidance on pulmonary tuberculosis drugs.

J&J Fined $2.2 Billion for Off-label Marketing and Kickbacks

November 4, 2013

Allegations include off-label marketing for Risperdal, Invega and Natrecor and kickbacks to doctors and pharmacists.

FDA Takes Actions to Prevent Drug Shortages

November 1, 2013

FDA releases a strategic plan and issues a proposed notification rule to improve prevention and resolution of drug shortage problems.

Teva CEO Steps Down

November 1, 2013

Jeremy Levin, CEO and president of Teva Pharmaceutical Industries steps down , and interim successor named.

ADVERTISEMENT

ADVERTISEMENT

Click here